Introduction
Recurrent pregnancy loss is caused by factors that disrupt the ability of a pregnancy to establish, implant, and continue normal development. In most cases, the underlying problem is not a single event but a biological disturbance in the embryo, uterus, maternal immune system, hormone signaling, blood clotting, or genetic makeup that interferes with early pregnancy maintenance. Some causes act before implantation, while others impair placental formation or fetal growth after pregnancy has already begun.
The major categories of causes include chromosomal abnormalities, structural and functional uterine problems, antiphospholipid syndrome and other clotting disorders, endocrine and metabolic disease, parental genetic abnormalities, immune and inflammatory disturbances, infection-related injury, and environmental or lifestyle influences. In many individuals, more than one factor contributes at the same time, which makes the condition complex and sometimes difficult to trace to a single source.
Biological Mechanisms Behind the Condition
A normal pregnancy depends on a precise sequence of events. A fertilized egg must divide normally, travel to the uterus, implant into a receptive endometrium, establish a placental connection, and then maintain adequate blood flow and nutrient exchange with the mother. Recurrent pregnancy loss develops when one or more of these steps repeatedly fails.
Early pregnancy is especially vulnerable to chromosomal errors. If an embryo carries too many or too few chromosomes, the cells cannot divide and mature in the correct pattern. The pregnancy may stop developing very early, often before a person realizes conception has occurred. This is one of the most common biological pathways behind repeated loss.
Another major mechanism is impaired placentation. The placenta must invade the uterine lining and remodel maternal spiral arteries so that blood flow can increase enough to support the embryo. If placental invasion is shallow, if the endometrium is not properly prepared, or if maternal blood vessels are blocked or inflamed, the embryo may receive insufficient oxygen and nutrients. The result can be early failure, growth arrest, or later miscarriage.
The maternal immune system also plays a role. Pregnancy requires tolerance toward fetal tissue, which contains paternal antigens. If immune signaling becomes excessively inflammatory or autoantibodies target pregnancy-related tissues, implantation and placental development may be compromised. Similarly, abnormal coagulation can create tiny clots in placental vessels, reducing blood supply to the embryo.
Primary Causes of Recurrent Pregnancy Loss
Chromosomal abnormalities are among the most common causes. These are errors in the number or structure of chromosomes in the embryo. They usually arise from mistakes in egg or sperm cell division, leading to an embryo that cannot develop normally. Because chromosome segregation is a highly complex process, even a healthy-looking embryo can carry a lethal genetic imbalance. When this happens repeatedly, it may reflect an increased chance of abnormal gamete formation or parental chromosomal rearrangement.
Parental balanced translocations or other rearrangements can also cause repeated loss. In these situations, one parent carries rearranged chromosomes but remains healthy because no genetic material has been lost or gained overall. During egg or sperm formation, however, the chromosomes may separate in a way that produces embryos with missing or extra segments. These embryos often fail early because essential genes are not present in the correct dosage.
Uterine structural abnormalities interfere with the physical environment needed for implantation and growth. Examples include a septate uterus, fibroids that distort the uterine cavity, intrauterine adhesions, and congenital abnormalities in uterine shape. These conditions can reduce space, alter blood supply, or create an endometrial surface that is poorly suited for embryo attachment. In some cases, the embryo implants in a site that cannot expand or vascularize adequately, leading to pregnancy failure.
Antiphospholipid syndrome is a major immune-mediated cause. This autoimmune disorder leads the body to produce antibodies against phospholipid-binding proteins. These antibodies promote abnormal clotting and inflammation in placental vessels and may also interfere with trophoblast function, which is the cell layer that helps the embryo invade the uterine lining. The combined effect is defective placental development and compromised fetal support.
Endocrine disorders contribute by disrupting the hormonal environment required for implantation and placental maintenance. Thyroid disease, uncontrolled diabetes, and luteal phase problems can alter ovulation, endometrial preparation, or early placental signaling. Progesterone is especially important because it stabilizes the uterine lining and helps maintain immune tolerance. If progesterone production is insufficient or if thyroid and glucose regulation are abnormal, the uterine environment may not support continued gestation.
Contributing Risk Factors
Genetic influences increase susceptibility in several ways. Some individuals inherit a tendency toward chromosomal instability, while others may carry variants that affect coagulation, immune regulation, or hormone metabolism. These inherited traits do not always cause pregnancy loss by themselves, but they can make the reproductive system more vulnerable when combined with other stressors.
Environmental exposures may damage developing embryos or interfere with implantation. Radiation, certain chemicals, heavy metals, and some medications can disrupt cell division, hormone signaling, or placental growth. The biological effect depends on dose, timing, and the stage of pregnancy. Exposure during the earliest weeks may be especially disruptive because embryonic cells are dividing rapidly and are highly sensitive to toxic injury.
Infections can contribute when they cause inflammation of the reproductive tract, placental tissue, or maternal bloodstream. Some infections may injure the endometrium directly, while others trigger a systemic immune response that alters placental function. Inflammatory cytokines can interfere with implantation and can damage the small blood vessels that nourish the early pregnancy.
Hormonal changes can affect pregnancy stability through the hypothalamic-pituitary-ovarian axis and through placental hormone production. Irregular ovulation, low progesterone, thyroid dysfunction, and elevated prolactin may all disturb the timing and quality of endometrial preparation. When the lining of the uterus is not synchronized with embryo development, implantation becomes less reliable and early loss becomes more likely.
Lifestyle factors such as tobacco use, heavy alcohol intake, poor nutritional status, and extreme obesity or underweight can influence pregnancy through vascular, hormonal, and inflammatory pathways. Smoking reduces uterine blood flow and exposes the embryo to toxins. Excess body fat can increase inflammation and disrupt insulin sensitivity, while inadequate nutrition may limit the substrates needed for rapid cell growth and placental formation.
How Multiple Factors May Interact
Recurrent pregnancy loss often reflects interaction among several biological systems rather than a single isolated defect. For example, a person with a mild uterine abnormality may still maintain pregnancy successfully unless an additional factor such as chromosomal embryo abnormality or antiphospholipid syndrome is present. In that situation, the uterine environment and embryo quality together fall below the threshold needed for continued development.
Endocrine and immune pathways also influence one another. Thyroid dysfunction can alter immune activity, and chronic inflammation can disturb hormone signaling and ovulation. Likewise, metabolic disease such as insulin resistance can increase inflammatory mediators and impair endometrial receptivity. When these changes combine, the pregnancy environment becomes less stable than any single defect would suggest.
Blood clotting abnormalities may also amplify the effect of other disorders. A uterus with reduced blood flow because of fibroids or scarring may be able to support a pregnancy only marginally. If clotting abnormalities further reduce placental perfusion, the embryo may not receive enough oxygen to survive. This overlap helps explain why some people experience repeated loss even when no single cause is dramatic on its own.
Variations in Causes Between Individuals
The cause of recurrent pregnancy loss differs from one person to another because reproductive biology is shaped by a combination of genetics, age, medical history, and environmental exposure. Age is especially important. As maternal age increases, the likelihood of chromosomal errors in eggs rises because egg cells remain arrested for many years before completing division. This raises the probability that embryos will carry aneuploidy, which is a major source of early loss.
Health status also changes the pattern of risk. A person with autoimmune disease is more likely to have immune-mediated loss, while someone with a history of uterine surgery may be more likely to have structural or scarring-related problems. A family history of translocations or clotting disorders may point to a hereditary mechanism. In contrast, repeated exposure to toxins, poor glycemic control, or smoking may produce a different biological profile centered on inflammation and vascular injury.
Environmental context matters as well. Access to nutrition, chronic stressors, occupational exposures, and infection risk can all alter reproductive physiology. Because pregnancy depends on many overlapping systems, different combinations of vulnerabilities can lead to the same clinical outcome. Two people may both experience recurrent loss, yet one may be affected mainly by embryo chromosomal abnormalities while the other has a uterine, endocrine, or autoimmune cause.
Conditions or Disorders That Can Lead to Recurrent Pregnancy Loss
Antiphospholipid syndrome is one of the best-established disorders linked to repeated miscarriage. By promoting thrombosis and inflammatory injury in the placental circulation, it undermines the blood supply required for fetal survival. The placenta is especially sensitive to microvascular blockage, so even small clotting defects can have major reproductive consequences.
Thyroid disorders, both hypothyroidism and hyperthyroidism, can contribute by disrupting ovulation, implantation, and placental signaling. Thyroid hormones influence nearly every tissue, including the reproductive tract. When levels are abnormal, the timing of endometrial development and the metabolic demands of early pregnancy may no longer align.
Diabetes mellitus increases risk when blood glucose is poorly controlled. High glucose affects egg quality, early embryonic development, and placental function. It also promotes oxidative stress and vascular injury, which can weaken the uterine environment needed to sustain pregnancy.
Polycystic ovary syndrome can lead to recurrent loss through hormonal and metabolic pathways. Ovulatory dysfunction can produce irregular progesterone exposure, while insulin resistance and inflammation may impair endometrial receptivity. The result is a less favorable environment for implantation and early placental formation.
Uterine conditions such as a septate uterus, submucosal fibroids, adenomyosis, or intrauterine adhesions can distort the cavity or damage the lining. These disorders interfere with implantation geometry, blood flow, and the ability of the uterus to expand as pregnancy progresses. When the cavity is physically abnormal, even a genetically normal embryo may not develop successfully.
Inherited thrombophilias are sometimes associated with pregnancy loss because they increase the tendency to form clots. Not every clotting variant has the same significance, but when placental vessels are repeatedly affected, fetal oxygenation may be reduced. The biological consequence is similar to other vascular disorders: inadequate placental perfusion.
Conclusion
Recurrent pregnancy loss develops when normal reproductive processes are repeatedly disrupted by genetic, structural, hormonal, immune, vascular, infectious, or environmental factors. The most important biological mechanisms involve chromosomal abnormalities in the embryo, defects in implantation or placental development, abnormal uterine anatomy, immune-mediated clotting and inflammation, and endocrine imbalance. These processes can act alone or in combination, which is why the condition has many possible causes and may look different from one individual to another.
Understanding these mechanisms clarifies why recurrent pregnancy loss occurs. It is not a single disorder with one universal explanation, but a pattern of repeated failure arising from specific physiological disturbances in embryo development, uterine support, maternal tolerance, and placental blood supply. The cause in any given person depends on how these systems interact and which step in pregnancy is most vulnerable.